This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium.

Video. US expert panel backs Pfizer vaccine for children aged 5 to 11

A US advisory committee backed the Pfizer COVID-19 vaccine for children ages five to 11, clearing the way for the vaccine to become available to millions of children.